Close
GS1 Global Healthcare Conference 2026
LiGHT 2026

Australia Pioneers The 3-D Printed Heart Tissue Treatment

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Related stories

GE HealthCare Secures CE Mark for...

GE HealthCare has secured CE Mark certification for its...

Revvity Launches GSP T1D 3plex Kit...

Revvity has launched the GSP T1D 3plex kit, a...

The Cigna Group Partners with OpenAI...

The Cigna Group has entered into a strategic partnership...

Researchers at the University of Technology Sydney (UTS) have proved that 3D bio-printed cardiac tissues can help patients recover from the damage caused by a massive heart attack in a safe and effective manner.

Cells taken from the patient’s blood are used to form the tissues. The researchers can then generate a 3D model of the patient’s heart and determine the damaged area before applying the new patch to the surface of the heart.

According to the head of the Cardiovascular Regeneration Group at UTS, Dr. Carmine Gentile, the study suggested that bio-engineered patches were the most effective and robust treatment for heart failure.

For the patient, these bio-engineered patches claim to be safer, more consistent, and more cost-effective. The findings were reported in Bioprinting, a world-renowned academic journal.

Cardiac failure is a consequence of cardiac disease in which a lack of blood supply causes the death of heart tissue in the affected area. Current treatments include heart transplants, which are an intrusive and dangerous procedure.

Because this method allows patients to use their own stem cells to make heart patches, not only can they potentially lessen the stress and cost of a heart transplant, but they can also circumvent obstacles such as the body rejecting donor tissues, according to Dr. Gentile.

Heart Research Australia, a crucial research funding partner, praised Dr. Gentile and his research team for their efforts to reduce the tragic statistics around heart disease.

It’s good to learn that this research collaboration has proven to be fruitful and can now move on to the next step. Nicci Dent, CEO of Heart Research Australia, added that they are very enthusiastic about the potential of this technology to help the hundreds of thousands of people who suffer from heart failure each year.

Before researchers commence clinical trials, more testing for the long-term consequences of this technology is being conducted.

Never miss a healthcare headline

Healthcare moves fast โ€“ stay on top of it with our must - read briefings.

  • The top hospital and healthcare stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments transforming global healthcare management

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media PackNow

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Latest stories

Related stories

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป